Prawo i regulacje · 03/06/2014

Hospira Notifies DEA of Controlled Substance Importation Plans

Hospira, a pharmaceutical company, has submitted a notice to the U.S. Drug Enforcement Administration (DEA) regarding its plans to import controlled substances, as required by law.